BAHD acyltransferase related to synthesis of acylated anthocyanin in blood orange, coding gene and application of BAHD acyltransferase

By cloning and expressing the acyltransferase CsAAT1 in blood orange, the problem of unreported acyltransferase gene in blood orange was solved, and the in vitro synthesis of acylated anthocyanins was achieved and the plant endoyl modification was promoted, and the citrus flavonoid synthesis pathway was promoted. and the biosynthesis of acylated anthocyanins.

CN119060978APending Publication Date: 2024-12-03ZHEJIANG UNIV +1
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411342346.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-25
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

At present, no clear acyltransferase genes are involved in anthocyanidination modification in blood oranges, which has affected the improvement of the citrus flavonoid synthesis pathway and the biological enzymatic synthesis of acylated anthocyanidins.

Method used

CsAAT1 in blood oranges was cloned and expressed, and recombinant proteins were purified by prokaryotic expression. A method of acylated anthocyanins was established in vitro enzymatic synthesis, using aliphatic Coenzyme A as an acyl donor to catalyze the anthocyanins. Acylation, it is speculated that CsAAT1 is involved in the synthesis of CMG in the ripening stage of blood orange pulp.

Benefits of technology

Successfully synthesized anthocyanins in vitro and increased anthocyanins content by transient overexpressing CsAAT1 in tobacco, proving that CsAAT1 catalyzes anthocyanins modification in plants, providing a theoretical basis for the biosynthesis of acylated anthocyanins. and application ideas.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060978A_ABST
    Figure CN119060978A_ABST
Patent Text Reader

Abstract

The invention discloses BAHD acyltransferase related to synthesis of acylated anthocyanin in blood oranges, a coding gene and application of the BAHD acyltransferase, and belongs to the technical field of engineering enzymes. The invention provides acyltransferase CsAAT1. The amino acid sequence of the acyltransferase CsAAT1 is as shown in SEQ ID No. 1. The expression of the CsAAT1 gene is basically consistent with the change trend of the CMG content in the blood orange pulp. The invention also establishes an anthocyanin in-vitro enzyme activity reaction system, and the aliphatic coenzyme A can be used as an acyl donor under in-vitro conditions to catalyze a plurality of anthocyanin monoglycosides to synthesize corresponding acylated anthocyanin. The invention also establishes an application of the CsAAT1 gene in cultivating plant varieties or strains which are modified by catalyzing anthocyanin acylation in vivo, and in the embodiment, an agrobacterium tumefaciens-mediated tobacco transient overexpression experiment proves that the CsAAT1 can increase the content of cyanidin-3-O-malonyl glucoside in the plant body, so that the content of cyanidin-3-O-malonyl glucoside in the plant body can be increased. And theoretical guidance is provided for improvement of anthocyanin components in plants.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of engineering enzymes and relates to BAHD acyltransferase related to the synthesis of acylated anthocyanins in blood orange, a coding gene and application thereof. Background Art

[0002] Citrus is a tree plant of the genus Citrus (Citrus L.) of the family Rutaceae. It is widely cultivated around the world. It is rich in flavonoids, organic acids, carotenoids, coumarins, essential oils and other bioactive substances. It has antioxidant, anti-cancer and anti-tumor effects, improves intestinal absorption rate, inhibits inflammation, prevents chronic diseases and other effects, and has a wide range of medicinal value. So far, more than 100 flavonoids have been identified from citrus plants, mainly including flavanones, flavonoids, flavonols and anthocyanins. The flavonoids in citrus vary depending on the variety, tissue location and development stage. For example, anthocyanins are only accumulated in the fruits of blood oranges and purple pomelo, and in the young buds and flowers of some varieties such as lemons. The most abundant anthocyanidin components in blood orange are cyanidin-3-O-glucoside (C3G) and cyanidin-3-O-(6”-malonyl glucoside) (CMG), which show a trend of first increasing and then decreasing during the ripening process. There are also significant differences in the content and proportion of the two in the peel and pulp.

[0003] The basic skeleton structure of flavonoids consists of two benzene rings (A and B) and a heterocyclic ring (C), which can be abbreviated as C6-C3-C6. It is usually further modified by hydroxylation, methylation, isoprenylation, acylation, etc. at different sites. These modifications also give flavonoid compounds structural and functional diversity. Among them, acylation is a common modification method after anthocyanidins form glycosides. Through the steric hindrance effect of the acyl group, it can further improve the coloring effect of anthocyanidins, enhance thermal stability and lipophilicity, and promote the transport and storage of anthocyanidins to the vacuole to prevent microbial glycosidases from degrading them. In addition, studies have reported that compared with unacylated anthocyanins, acylated anthocyanins have a more obvious effect on increasing half-life and have a greater regulatory effect on intestinal flora and blood sugar metabolism. At present, a variety of acylated anthocyanidins have been detected in crops such as blood oranges, grapes, strawberries, cabbages, and purple potatoes, and have broad prospects in many fields such as food pigments, health products, and intelligent packaging detection.

[0004] Acyltransferases involved in the acylation of secondary metabolites in plants usually exist in the form of protein families, among which the proteins related to the acylation modification of polyphenolic compounds mainly include the BAHD family and the SCPL family. Among them, the BAHD family is named after the first letters of the four types of acyltransferases in the family, including benzylalcohol O-acetyltransferase (BEAT), anthocyanin O-hydroxycinnamoyltransferase (AHCT), anthranilate N-hydroxycinnamoyl / benzoyltransferase (HCBT) and deacetylvindoline 4-O-acetyltransferase (DAT), involving the widest range of secondary metabolites and the richest variety. According to the classic phylogenetic evolutionary classification of the BAHD family by D'Auria in 2006, BAHD genes related to the structural modification of phenolic glycoside compounds belong to the Ia branch, and aliphatic acylation reactions are mostly involved. However, there are few studies on acyltransferases (AT) that regulate anthocyanin biosynthesis and modification in fruit trees, and even fewer have completed functional identification. So far, the relevant acyltransferase genes that catalyze C3G to produce CMG in blood orange have not been reported. Identifying AT involved in the acylation modification of anthocyanins in blood orange is not only conducive to further improving the synthesis pathway of citrus flavonoids, but also provides a theoretical basis and application ideas for the bioenzymatic synthesis of acylated anthocyanins. Summary of the invention

[0005] The invention provides BAHD acyltransferase related to the synthesis of acylated anthocyanins in blood orange, a coding gene and application thereof. The BAHD acyltransferase can undergo a catalytic reaction in vitro and can be used as a key enzyme for catalyzing the synthesis of acylated anthocyanins in citrus.

[0006] The present invention provides an acyltransferase CsAAT1, wherein the amino acid sequence of the acyltransferase CsAAT1 comprises any one of the following: (1) the amino acid sequence shown in SEQ ID No. 1;

[0007] (2) Compared with the sequence shown in SEQ ID No. 1, one or more amino acids are added, deleted or substituted, and the function of acyltransferase is not affected.

[0008] The present invention also provides a gene encoding the above-mentioned acyltransferase CsAAT1, wherein the nucleotide sequence of the gene comprises any one of the following: (1) the nucleotide sequence shown in SEQ ID No. 2;

[0009] (2) A sequence having 90% or more homology with the sequence shown in SEQ ID No. 2.

[0010] The present invention also provides a primer pair for amplifying the above gene, comprising an upstream primer with a nucleotide sequence as shown in SEQ ID No.3 and a downstream primer as shown in SEQ ID No.4.

[0011] The present invention also provides a recombinant expression vector comprising the gene and expressing the acyltransferase CsAAT1.

[0012] The present invention also provides a host cell expressing the acyltransferase CsAAT1.

[0013] The present invention also provides a method for producing the acyltransferase CsAAT1, comprising inducing the host cell to express, extracting and purifying to obtain the acyltransferase CsAAT1.

[0014] The present invention also provides the use of the acyltransferase CsAAT1 or the acyltransferase CsAAT1 produced by the above method in in vitro enzymatic synthesis of acylated anthocyanins.

[0015] The present invention also provides a method for synthesizing acylated anthocyanins by enzymatic method in vitro, comprising the following steps: using aliphatic coenzyme A as an acyl donor and anthocyanins as substrates to configure an enzyme reaction system for enzyme catalysis reaction to obtain acylated anthocyanins.

[0016] In a specific embodiment of the present invention, the aliphatic CoA includes malonyl-CoA or acetyl-CoA;

[0017] The anthocyanin includes cyanidin-3-O-glucoside, peonidin-3-O-glucoside, delphinidin-3-O-glucoside or cyanidin-3-O-galactoside.

[0018] The present invention also provides the use of the above gene in cultivating plant varieties or strains that catalyze the acylation modification of anthocyanins in vivo.

[0019] Beneficial effects: The present invention provides an acyltransferase CsAAT1, which is cloned from blood orange for the first time, and in the embodiment, the CsAAT1 recombinant protein is expressed and purified by prokaryotic expression, and its amino acid sequence includes SEQ ID No. 1. The expression amount of the gene encoding the acyltransferase CsAAT1 of the present invention is basically consistent with the content change trend of CMG in blood orange pulp, and it is speculated that the CsAAT1 gene is involved in the synthesis of CMG in the ripening period of blood orange pulp.

[0020] The present invention also establishes an in vitro enzyme activity reaction system for anthocyanins, which can catalyze the synthesis of corresponding acylated anthocyanins from a variety of anthocyanidin monosaccharides using aliphatic coenzyme A as an acyl donor under in vitro conditions. The products can be detected by high performance liquid chromatography (HPLC) and identified by liquid chromatography-tandem mass spectrometry (LC-MS / MS), providing a way of thinking for the efficient synthesis of acylated anthocyanins by in vitro enzymatic methods in the future.

[0021] The present invention also establishes the application of the CsAAT1 gene in cultivating plant varieties or strains that catalyze the acylation modification of anthocyanins in vivo. In the examples, the tobacco transient overexpression experiment mediated by Agrobacterium tumefaciens is used to prove that CsAAT1 can increase the content of cyanidin-3-O-malonyl glucoside in plants, providing theoretical guidance for the improvement of anthocyanin components in plants. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 The graph shows the changes in C3G and CMG content and the expression pattern analysis of CsAAT1 in freeze-dried blood orange pulp at different developmental stages;

[0023] Figure 2 The figure is the SDS-PAGE electrophoresis result of blood orange CsAAT1 recombinant protein and pET32a(+) empty protein;

[0024] Figure 3 The in vitro enzyme activity HPLC analysis spectrum of CsAAT1 recombinant protein using cyanidin-3-O-glucoside as substrate and malonyl-CoA as acyl donor, the LC-MS / MS spectrum of the product and the LC-MS / MS spectrum of chlorocyanidin-3-O-(6”-malonyl glucoside) standard;

[0025] Figure 4 The in vitro enzyme activity HPLC analysis and LC-MS / MS spectra of CsAAT1 recombinant protein using paeonidin-3-O-glucoside, delphinidin-3-O-glucoside, cyanidin-3-O-galactoside as substrates and malonyl-CoA as acyl donor and using cyanidin-3-O-glucoside as substrate and acetyl-CoA as acyl donor respectively;

[0026] Figure 5 To analyze the coloration of tobacco leaves with transient overexpression of CsAAT1 and the expression of key structural genes in the anthocyanin biosynthesis pathway of CsAAT1;

[0027] Figure 6 The HPLC analysis spectrum of anthocyanin extracts from tobacco leaves with transient overexpression of CsAAT1 and the LC-MS / MS spectrum of new products;

[0028] Figure 7 This is the subcellular localization map of CsAAT1. DETAILED DESCRIPTION

[0029] The present invention provides an acyltransferase CsAAT1, wherein the amino acid sequence of the acyltransferase CsAAT1 comprises any one of the following: (1) the amino acid sequence shown in SEQ ID No. 1;

[0030] (2) Compared with the sequence shown in SEQ ID No. 1, one or more amino acids are added, deleted or substituted, and the function of acyltransferase is not affected.

[0031] In a specific embodiment of the present invention, the amino acid sequence is shown in SEQ ID No. 1: MNIISSRCVKIREVTRVTPFFDSTASTNDNPLPSTALALTYFDTKWFKFPPVQRLFYRNQTSDNDSIRFNSEILPQLKHSLSLALLHYLPLAGHIMWPELETKPAVYYFPDQKCDGVSFVVAESSDADFDRVSGDGILEAAEYHPLVPQLSITEDKAEVIAIQITLFPNQGFSIGVSAHHAVLDGKSTTLFIKSWAYLCKQLKLQQQQQQTYLPPELTPCFDRTVVKDPDGIDMIY LKHWMSGSSSNRRSLNVMPVKPENYYSNLVRMTFELNREDINKLREKVNKVLYSTQGGAQYLSSFVITCAHVFVWLVKARDVEANTTVRFVIATDCRSRLDPPIPANYFGNCTGGEFGEAKA SDFMQENGVAFVAHKLSDLIKGIKQGAVLGSEDEFLNGMAKMREAQQLKISVAGSNRFDVYGSDFGWGRPEKVEVVSIDTTGAISLAETRDGGGGFEIGVVLEKQQMEVFASLFVDALKDL.

[0032] The present invention also provides a gene encoding the above-mentioned acyltransferase CsAAT1, wherein the nucleotide sequence of the gene comprises any one of the following: (1) the nucleotide sequence shown in SEQ ID No. 2;

[0033] (2) A sequence having 90% or more homology with the sequence shown in SEQ ID No. 2.

[0034] In one embodiment of the present invention, the acyltransferase gene CsAAT1 can be cloned from blood orange pulp, or from different tissue parts of blood orange or other sweet orange varieties (such as sugar orange), and the CsAAT1 gene sequences cloned from different varieties are slightly different, but they all have 90% or more homology with the nucleotide sequence shown in SEQ ID No.2 and fall within the protection scope of the present invention.

[0035] The present invention also provides a primer pair for amplifying the above gene, comprising an upstream primer with a nucleotide sequence as shown in SEQ ID No.3 and a downstream primer as shown in SEQ ID No.4.

[0036] In one embodiment of the present invention, the CsAAT1 gene is cloned from blood orange pulp, and the primer pairs used include:

[0037] Upstream primer, SEQ ID No. 3: ATGAATATCATCAGCAGCAG;

[0038] Downstream primer, SEQ ID No. 4: TCAAAGATCTTTGAGGGCATC.

[0039] The cloning of the present invention uses cDNA synthesized by reverse transcription of pulp RNA as a template to construct a PCR amplification system. The 50 μL reaction system includes: 2×PhantaMaxMasterMix (Dye Plus) 25 μL, 2 μL of upstream and downstream primers (10 μM), 2.5 μL of cDNA, and 18.5 μL of DEPC water. The PCR program is: 95°C pre-denaturation for 3 min; 95°C for 15 s, 58°C for 15 s, 72°C for 70 s, 35 cycles; 72°C for 5 min, and 4°C storage. The sequence obtained by PCR amplification is shown in SEQ ID No. 2.

[0040] The present invention also provides a recombinant expression vector comprising the gene and expressing the acyltransferase CsAAT1.

[0041] The present invention does not specifically limit the basic backbone vector of the recombinant expression vector. For example, in a specific embodiment, a prokaryotic expression vector is used as the basic backbone vector, such as the pET-32a(+) vector in the embodiment, and the nucleotide sequence shown in SEQ ID No.2 is connected to the BamHI and XhoI restriction sites of the pET-32a(+) vector to construct a recombinant expression vector pET-32a(+)-CsAAT1 that can express the above-mentioned acyltransferase CsAAT1. Of course, the basic backbone vector of the recombinant expression vector can also be other types of vectors, such as a eukaryotic expression vector.

[0042] The present invention also provides a host cell expressing the acyltransferase CsAAT1.

[0043] The present invention does not specifically limit the basic cells of the host cells. For example, in one embodiment, a prokaryotic cell such as Escherichia coli is used as a host, and the recombinant expression vector is transformed into the host to construct an engineered cell. Of course, eukaryotic cells can also be used as long as they are compatible with the eukaryotic expression vector.

[0044] The present invention also provides a method for producing the acyltransferase CsAAT1, comprising inducing the host cell to express, extracting and purifying to obtain the acyltransferase CsAAT1.

[0045] In a specific embodiment of the present invention, the acyltransferase CsAAT1 is expressed, extracted and purified by prokaryotic expression.

[0046] The present invention also provides the use of the acyltransferase CsAAT1 or the acyltransferase CsAAT1 produced by the above method in in vitro enzymatic synthesis of acylated anthocyanins.

[0047] The acyltransferase CsAAT1 of the present invention has in vitro enzyme activity and can synthesize acylated anthocyanins in vitro.

[0048] The present invention also provides a method for synthesizing acylated anthocyanins by enzymatic method in vitro, comprising the following steps: using aliphatic coenzyme A as an acyl donor and anthocyanins as substrates to configure an enzyme reaction system for enzyme catalysis reaction to obtain acylated anthocyanins.

[0049] In a specific embodiment of the present invention, the aliphatic CoA may be malonyl CoA or acetyl CoA; the anthocyanin may be cyanidin-3-O-glucoside (C3Glc), peonydin-3-O-glucoside (P3Glc), delphinidin-3-O-glucoside (D3Glc) or cyanidin-3-O-galactoside (C3Gal).

[0050] In the embodiment of the present invention, the system of the enzyme catalytic reaction can be 50 μL, including: 50 mM KPB buffer (pH=6.5), 300 μM anthocyanin substrate, 200 μM acyl donor, 5 μL (5-10 μg) purified CsAAT1 recombinant protein, and then incubated at 30° C. in the dark for 4 hours to perform the enzyme catalytic reaction.

[0051] The present invention also provides the use of the above gene in cultivating plant varieties or strains that catalyze the acylation modification of anthocyanins in vivo.

[0052] In one embodiment of the present invention, the gene CsAAT1 is transiently overexpressed in tobacco, the red color of tobacco leaves deepens, the total anthocyanin content increases, and the overexpression of CsAAT1 may activate the gene expression in the anthocyanin synthesis pathway as a whole, thereby increasing the total anthocyanin content; and cyanidin-3-O-malonyl-glucoside can be produced, indicating that CsAAT1 has the function of catalyzing the acylation modification of anthocyanins in plants, and shows certain application prospects in the field of biosynthesis of acylated anthocyanins.

[0053] To further illustrate the present invention, the BAHD acyltransferase, encoding gene and application thereof related to the synthesis of acylated anthocyanins in blood orange provided by the present invention are described in detail below in conjunction with the examples, but they should not be construed as limiting the scope of protection of the present invention.

[0054] Example 1 Gene cloning of CsAAT1

[0055] 1. Experimental Methods

[0056] The "Taroko" blood orange was used as the experimental material, and the FastPure Universal Plant Total RNA Isolation Kit (Vazyme, China) was used to extract RNA, and 0.3 g of non-freeze-dried fruit jelly powder was added according to the instructions. The above RNA was used as a template, and 1 μg of RNA was added to the HiScript III 1st Strand cDNA Synthesis Kit according to the instructions to synthesize cDNA by reverse transcription. The obtained cDNA was diluted 10 times as a template for amplification, and the amplification primer sequences were SEQ ID No. 3 and SEQ ID No. 4.

[0057] The gene cloning reaction system was 50 μL, including: 2×PhantaMax MasterMix (Dye Plus) 25 μL, upstream and downstream primers (10 μM) 2 μL each, cDNA 2.5 μL, DEPC water 18.5 μL. The PCR program was: 95°C pre-denaturation for 3 min; 95°C 15 s, 58°C 15 s, 72°C 70 s, 35 cycles; 72°C 5 min, 4°C hold.

[0058] After the PCR product was detected by agarose gel electrophoresis, the gel block containing the target band was cut out and the target DNA was recovered using the Easy Gel Extraction & Clean-up Kit (EasyStud, China), connected to the pGEM-T-Easy vector, and transformed into Escherichia coli DH5α by heat shock method. The bacterial liquid was spread on LB solid medium containing 50 mg / L kanamycin (Kan) and incubated in an inverted incubator at 37°C for 12 to 14 hours, and then the colonies of appropriate size were picked for PCR verification.

[0059] The bacterial test system is 10μL, including: 2×RapidMix 5μL, upstream and downstream primers (10μM) 0.4μL each, bacterial solution 0.5μL, DEPC water 3.7μL. The PCR program is: 95℃ pre-denaturation 3min; 95℃ 15s, 58℃ 15s, 72℃ 40s, 35 cycles; 72℃ 5min, 4℃ hold. After agarose gel electrophoresis detection, select samples with correct bacterial test bands for verification.

[0060] 2. Experimental Results

[0061] After sequencing and comparison, the nucleotide sequence encoded by CsAAT1 is shown in SEQ ID No. 2, with a length of 1443 bp, and has the highest consistency with the CDS sequence of Cs_ont_7g006330.1 in the sweet orange 3.0 genome database (http: / / citrus.hzau.edu.cn / index.php), with a coverage rate of 98.14%. According to the full-length CDS sequence of CsAAT1, the protein sequence obtained by translation using the Expasy software tool (https: / / web.expasy.org / translate / ) is shown in SEQ ID No. 1, with a total of 480 amino acids.

[0062] Example 2 Analysis of CsAAT1 expression patterns at different developmental stages of blood orange fruit

[0063] 1. Experimental Methods

[0064] Blood orange fruits were picked at different stages after flowering (DAF230, DAF250, DAF270, DAF290, DAF310, and DAF330), and three biological replicates were set for each stage, with four fruits in one biological replicate. The pulp was quickly frozen in liquid nitrogen and placed in a -80°C refrigerator for later use.

[0065] Extraction and content determination of anthocyanins: Put the blood orange pulp that has been quick-frozen by liquid nitrogen into a vacuum freeze dryer and dry it for 72 hours, then grind it into powder. Weigh 0.1g of powder under light-proof conditions and add 400μL of methanol containing 1% concentrated hydrochloric acid. Extract in the dark at 4℃ for 24 hours, then centrifuge at 12000rpm for 30min to collect the supernatant, and draw 100μL into a brown liquid phase bottle for HPLC detection. The remaining extract is added to a 1.5mL centrifuge tube wrapped in tin foil and stored in a refrigerator at -20℃.

[0066] The HPLC detection system is as follows: mobile phase B is 5% formic acid water, mobile phase C is chromatographic methanol, flow rate is 0.8 mL / min, column temperature is 25°C, injection volume is 10 μL. The gradient elution program is: 0-2 min, 10% C; 2-5 min, 10-15% C; 5-15 min, 15-20% C; 15-20 min, 20-27% C; 20-25 min, 27% C; 25-42 min, 27-35% C; 42-52 min, 35%-27% C; 52-54 min, 10% C. The detection wavelength is 520 nm.

[0067] Analysis of CsAAT1 expression pattern in blood orange pulp at different developmental stages: HiScript III RT SuperMix for qPCR (+gDNAwiper) (Vazyme, China) kit was used, and 800 ng of RNA extracted in Example 1 was added according to the instructions for reverse transcription into cDNA.

[0068] The RT-qPCR reaction system was 10 μL, including: 5 μL 2×ChamQ Universal SYBR qPCR Master Mix (Vazyme, China), 0.2 μL each of upstream and downstream primers (10 μM), 1 μL of cDNA diluted 5 times, and 3.6 μL of ddH2O.

[0069] The PCR program was as follows: pre-denaturation at 95°C for 3 min, 40 cycles of 95°C for 5 s, and 60°C for 30 s; 95°C for 10 s, and the melting curve was from 65°C to 95°C, increasing by 0.5°C every 5 s.

[0070] The primers for the citrus internal reference gene β-actin are SEQ ID No.5 and SEQ ID No.6, and the RT-qPCR primers for CsAAT1 are SEQ ID No.7 and SEQ ID No.8.

[0071] SEQ ID No.5: CATCCCTCAGCACCTTCC;

[0072] SEQ ID No.6:CCAACCTTAGCACTTCTCC;

[0073] SEQ ID No.7:AAAGGGATAAAGCGGGGTGC;

[0074] SEQ ID No. 8: TGTTGTGCTCTCCGCATCTT.

[0075] 2. Experimental Results

[0076] The accumulation pattern of anthocyanins in blood orange pulp at different developmental stages was analyzed, e.g. Figure 1 As shown in the data, anthocyanins were almost undetectable before 230 days after flowering. After 250 days, the contents of cyanidin-3-O-glucoside (C3G) and cyanidin-3-O-(6”-malonyl glucoside) (CMG) showed an upward trend, which increased rapidly after 310 days. The CMG content reached a maximum of 0.166 mg / g DW on 330 days. The expression of CsAAT1 showed a trend of first increasing and then decreasing, with the highest expression level at DAF270-DAF290, which was similar to the accumulation pattern of C3G and CMG content, but the peak appeared earlier. It is speculated that CsAAT1 may be involved in the synthesis of CMG during the ripening period of blood orange pulp.

[0077] Example 3 Prokaryotic expression and protein purification of CsAAT1

[0078] 1. Experimental Methods

[0079] (1) Construction of recombinant vector: The sequenced CsAAT1-T-Easy vector was used as a template for amplification, and the homologous recombination primers were SEQ ID No. 9 and SEQ ID No. 10. The PCR product was recovered by gel extraction, ligated to the pET-32a(+) vector double-digested with restriction endonucleases BamHI and XhoI, and transformed into Escherichia coli DH5α by heat shock method. The bacterial solution was spread on LB solid medium containing 100 mg / L ampicillin (Amp), inverted and cultured at 37°C for 12 to 14 hours, and the CsAAT1-pET32a recombinant plasmid was obtained after spot detection, colony PCR and verification.

[0080] SEQ ID No.9: GGCTGATATCGGATCCATGAATATCATCAGCAGCAGATG;

[0081] SEQ ID No. 10: GGTGGTGGTGCTCGAGAAGATCTTTGAGGGCATCAAC.

[0082] (2) Recombinant protein expression: The CsAAT1-pET32a recombinant plasmid and the pET32a(+) empty vector plasmid were transferred into Escherichia coli BL21(DE3) by chemical transformation. The sample bacterial suspension with the correct colony PCR band was selected, and 500 μL of liquid culture medium containing Amp was added. After overnight culture at 37°C and 200 rpm in a shaking incubator, 500 μL of 50% sterile glycerol was added and the suspension was stored in a -80°C refrigerator for use.

[0083] Take 10 μL of the stored bacterial solution and streak culture, pick a single colony to 20 mL of LB liquid medium containing Amp, shake at 37°C, 200 rpm overnight. Then take 10 mL of bacterial solution and continue shaking at a ratio of bacterial solution: LB liquid medium = 1:10 until OD 600 The value reaches 0.6~0.8.

[0084] Add IPTG to the above bacterial solution at a final concentration of 0.5 mM and induce at 16°C, 150 rpm for 20 hours until OD 600 value ≥ 2.0. Centrifuge at 4000 rpm for 15 min at 4℃, discard the supernatant to collect the bacteria, add 20-25 mL of 1×PBS solution to the precipitate to resuspend the bacteria, transfer the resuspension to a 50 mL centrifuge tube, and freeze at -80℃ for more than 48 hours.

[0085] (3) Protein purification: Take out the resuspension stored in a -80℃ refrigerator, thaw in a 30℃ water bath, use a cell disruptor to disrupt the cells for 5-10 minutes (work for 3 seconds and 2 seconds intervals), then centrifuge at 4℃, 10000rpm for 30 minutes, and keep the supernatant, which contains the target protein. After removing impurities through a PES membrane with a pore size of 0.45μm, use a HisTALONTM (Takara, Japan) gravity column to purify the crude protein. Pipette 20μL of the eluted protein into a PCR tube, add 5μL of 6×Protein Sample Loading Buffer, denature and inactivate the protein at 98℃ for 5min, and quickly cool to 4℃. Then perform SDS-PAGE gel electrophoresis detection, Coomassie Brilliant Blue staining and boiling decolorization, and take photos to observe the protein purification results. The remaining protein was eluted into a centrifuge tube through a PD-10 desalting column using a Tris-HCl buffer (pH=7.0) containing 10% glycerol and stored in a -80°C refrigerator until use.

[0086] 2. Experimental Results

[0087] The SDS-PAGE electrophoresis results of CsAAT1 recombinant protein and pET32a(+) empty protein are as follows Figure 2As shown, after adding the His tag, the band size of the CsAAT1 recombinant protein is about 73 kDa, and the theoretical value is 73.94 kDa; the band size of the pET32a(+) empty protein is about 20 kDa, and the theoretical value is 20.40 kDa, both of which are within a similar range and can be used for subsequent in vitro enzyme activity experiments.

[0088] Example 4 In vitro enzymatic activity of CsAAT1 recombinant protein and product identification

[0089] 1. Experimental Methods

[0090] Using malonyl-CoA and acetyl-CoA as acyl donors, four anthocyanins, cyanidin-3-O-glucoside (C3Glc), peony-3-O-glucoside (P3Glc), delphinidin-3-O-glucoside (D3Glc), and cyanidin-3-O-galactoside (C3Gal), were selected as substrates for in vitro enzyme activity experiments. The reaction system was 50 μL, containing 50 mM KPB buffer (pH = 6.5), 300 μM anthocyanin substrate, 200 μM acyl donor, 5 μL (5-10 μg) purified CsAAT1 recombinant protein or pET32a (+) empty protein. After incubation at 30 ° C in the dark for 4 hours, 50 μL of 0.5% trifluoroacetic acid was added, vortexed thoroughly to terminate the reaction, centrifuged at 4 ° C 12000 rpm for 15 minutes, and 80 μL of supernatant was taken into a brown liquid phase bottle for testing. The HPLC system and detection wavelength were consistent with those in Example 2. The in vitro enzyme activity reaction products and cyanidin-3-O-(6"-malonyl glucoside) standard were identified by LC-MS / MS.

[0091] An AB TripleTOF 5600plus time-of-flight liquid-mass spectrometer (AB SCIEX, USA) was used for mass spectrometry analysis in positive ion scanning mode: ion source temperature (TEM) 550°C, voltage (IS) 5500 V; nebulizer (GS1), auxiliary nebulizer (GS2), curtain gas (CUR) pressures 55 psi, 55 psi, 35 psi, respectively; scanning range (m / z) 100-2000 Da.

[0092] 2. Experimental Results

[0093] like Figure 3As shown, when malonyl-CoA is used as the acyl donor and cyanidin-3-O-glucoside is used as the substrate, CsAAT1 can catalyze the generation of a single product peak compared to the empty protein. By comparing the retention time and ion fragment information of the product peak and the standard, the product was determined to be cyanidin-3-O-(6”-malonyl glucoside), the molecular ion peak in the positive ion mode is 535, and the secondary mass spectrometry fragment at m / z 287 indicates the loss of one molecule of malonate [M-86] and one molecule of hexose [M-162]. In addition, when malonyl-CoA is used as the substrate, three anthocyanins, peony-3-O-glucoside, delphinidin-3-O-glucoside, and cyanidin-3-O-galactoside, are selected as substrates, or when acetyl-CoA is used as the acyl donor and cyanidin-3-O-glucoside is selected as the substrate, CsAAT1 can also catalyze the generation of a single new product peak. The results are shown in the figure. Figure 4 Although there is no standard as a reference, according to the Reaxys database information and the mass spectrometry information of anthocyanin metabolites of citrus plants reported in the literature, it is judged that CsAAT1 can catalyze the production of peonidin-3-O-malonyl glucoside, delphinidin-3-O-malonyl glucoside, cyanidin-3-O-malonyl galactoside or cyanidin-3-O-acetylglucoside.

[0094] The above results indicate that, under in vitro conditions, CsAAT1 can use malonyl-CoA and acetyl-CoA, two common aliphatic CoA molecules, as acyl donors to catalyze the production of corresponding acylated anthocyanins from a variety of anthocyanin monosaccharides.

[0095] Example 5 Construction of transient overexpression tobacco and identification of metabolites

[0096] 1. Experimental Methods

[0097] The CsAAT1-T-Easy vector with correct sequencing was used as a template for cloning, and the primers are shown in SEQ ID No.11 and SEQ ID No.12. The recovered product was connected to the pGreen II002962-SK vector that was double-digested with restriction endonucleases EcoRI and XhoI, and finally the CsAAT1-SK recombinant plasmid was obtained. 400 ng of the recombinant plasmid and the SK empty plasmid were respectively added to 30 μL EHA105 strains, and the mixture was slowly pipetted and mixed, and then placed on ice for 5 minutes, liquid nitrogen for 5 minutes, and 37°C water bath for 5 minutes. After 5 minutes of ice bath, the bacteria were shaken and cultured. The bacterial liquid was spread on LB solid culture medium containing 50 mg / L kanamycin (Kan) and 20 mg / L rifampicin (Rif), and placed in a 28°C oven for 48 to 72 hours. The samples with correct bands were screened by colony PCR, and 50% sterile glycerol was added and stored in a -80°C refrigerator.

[0098] SEQ ID No.11: CGGGCTGCAGGAATTCATGAATATCATCAGCAGCAGATG;

[0099] SEQ ID No. 12: CGGGCCCCCCCTCGAGTCAAAGATCTTTGAGGGCATC.

[0100] The EHA105 strain of the CsRuby1-CsNoemi-SK vector was constructed in the laboratory in the early stage and has been published in the article (Wang Y, Li S, Shi Y, Lv S, Zhu C, Xu C, Zhang B, Allan AC, Grierson D, Chen K. The R2R3MYB Ruby1 is activated by two cold responsive ethylene response factors, via the retrotransposon in its promoter, to positively regulate anthocyanin biosynthesis in citrus [J]. The Plant Journal. 2024 Aug; 119 (3): 1433-1448.) After injection, anthocyanins can be accumulated in tobacco leaves, which is convenient for naked eye observation and content detection.

[0101] Pipette 10 μL of the preserved bacterial solution and streak it onto LB solid medium containing Kan and Rif and culture it for 2 days. Use a spreading stick to dip some colonies and spread them on a new LB plate with the same resistance. Secondary activation for 12 hours, scrape the bacteria with an inoculation stick and resuspend them in infection solution (containing 10 mM MES, 10 mM MgCl2, 150 μM AS), and adjust the OD 600 The volume ratio of the control group CsRuby1-CsNoemi-SK:SK empty load infection solution was 1:1, and the volume ratio of the experimental group CsRuby1-CsNoemi-SK:CsAAT1-SK infection solution was 1:1. After mixing, measure the OD again. 600 Adjust to 0.75-0.85 and it can be used for tobacco injection.

[0102] Select large tobacco (Nictiana tabacum) 40 to 50 days after sowing, which grows well and has the same growth on the left and right sides of the leaves as experimental materials. Use a 1mL syringe without a needle to draw the infection solution and inject it on the back of the leaf. The left side is injected into the control group and the right side is injected into the experimental group. One leaf is a repetition. After the injection, the tobacco is placed in a culture room at 25°C and a light / dark cycle of 16h / 8h for 7 days, and then photographed to record the coloring of the leaves. Take the infected leaf area, quick-freeze it with liquid nitrogen, grind the sample, and place it in a -80°C refrigerator for standby use. Refer to Example 2 for the anthocyanin extraction and detection method.

[0103] Primers for the tobacco internal reference gene Actin are shown in SEQ ID No. 13 and SEQ ID No. 14. In addition, RT-qPCR primers for key structural genes in the tobacco anthocyanin synthesis pathway were designed, including primers for NtDFR as shown in SEQ ID No. 15 and SEQ ID No. 16, primers for NtANS as shown in SEQ ID No. 17 and SEQ ID No. 18, and primers for NtUFGT as shown in SEQ ID No. 19 and SEQ ID No. 20.

[0104] SEQ ID No.13: GCCCAACACTTCTTGATGCTC;

[0105] SEQ ID No.14: GACACCAGTTTCCACACGAC;

[0106] SEQ ID No.15: CCAAAGGCAGAGGGGAGATT;

[0107] SEQ ID No.16:TCCGGCATTTCTCTTGGAC;

[0108] SEQ ID No.17:GAAGGAAGTCGGAGGCAAGG;

[0109] SEQ ID No.18: AGCTTCAACGCCAAGTGCTA;

[0110] SEQ ID No.19:CCCCTATTGGACGTGAAGCC;

[0111] SEQ ID No. 20: CCACTTTCCTCCTCTGCCATT.

[0112] 2. Experimental Results

[0113] like Figure 5As shown in the figure, compared with the control group injected with CsRuby1-CsNoemi and EV, the red color of tobacco in the experimental group injected with CsRuby1-CsNoemi and CsAAT1 deepened, indicating that the total anthocyanin content increased. The transcription level of CsAAT1 was significantly upregulated (increased by 18.86 times). At the same time, the expression levels of key structural genes ANS, DFR and UFGT downstream of the tobacco anthocyanin synthesis pathway increased. It is speculated that overexpression of CsAAT1 may have activated the gene expression in the anthocyanin synthesis pathway as a whole, thereby increasing the total anthocyanin content.

[0114] In addition, anthocyanins were extracted from tobacco leaves of the control group and the experimental group and tested by HPLC. The results were as follows Figure 6 As shown. It was found that compared with the control group, the contents of rutin, cyanidin-3-O-glucoside and cyanidin-3-O-rutinoside in the three main extracts of the experimental group increased (corresponding to P1, P2, and P3 in the HPLC spectrum, respectively), and a new product peak P4 appeared. The product peak was analyzed by LC-MS / MS and identified as cyanidin-3-O-malonyl-glucoside. This shows that CsAAT1 has the function of catalyzing the acylation modification of anthocyanins in plants, and shows certain application prospects in the field of biosynthesis of acylated anthocyanins.

[0115] Example 6 Subcellular localization of CsAAT1

[0116] 1. Experimental Methods

[0117] The CsAAT1-T-Easy vector with correct sequencing was used as a template for cloning, and the primers are shown in SEQ ID No.21 and SEQID No.22. The recovered product was connected to the pCAMBIA1300-35S-eGFP vector after restriction endonuclease BamHI digestion, and finally the CsAAT1-eGFP recombinant plasmid was obtained. The recombinant plasmid was transformed into the Agrobacterium strain GV3101 by chemical transformation, and the cultured bacterial solution was spread on the LB solid medium containing 50 mg / L kanamycin (Kan) and 25 mg / L gentamicin (Get), placed in a 28°C oven for 48 to 72 hours, and a single colony was picked for PCR verification. The bacterial solution with the correct band was selected and added with 50% sterile glycerol and stored in a -80°C refrigerator. Agrobacterium containing pCAMBIA1300-35S-eGFP empty vector was used as a control.

[0118] SEQ ID No.21: CGGTACCCGGGGATCCATGAATATCATCAGCAGCAGATG;

[0119] SEQ ID No. 22: CGACTCTAGAGGATCCAAGATCTTTGAGGGCATC.

[0120] Four-week-old Nicotiana benthamiana with good growth was selected as the experimental material for subcellular localization. The Agrobacterium strain was activated twice and then resuspended in the MES-NaOH infection solution described in Example 5. The OD 600 The value was adjusted to 1.0. A 1mL syringe needle was used to poke a small hole in the tobacco leaf, and then the infection solution was sucked into the small hole with a 1mL syringe and injected from the back of the leaf. The injected tobacco was cultured in a culture room at 25°C with a light / dark cycle of 16h / 8h for 48 hours, and then the subcellular localization of CsAAT1 was recorded using an ultra-high resolution laser confocal microscope.

[0121] 2. Experimental Results

[0122] like Figure 7 As shown, the fluorescence signals of the control protein (35s::eGFP empty vector) and CsAAT1-GFP can be detected in both the nucleus and cytoplasm, indicating that CsAAT1 is localized in the nucleus and cytoplasm.

[0123] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.

Claims

1. An acyltransferase CsAAT1, It is characterized in that The amino acid sequence of the acyltransferase CsAAT1 includes any one of the following: (1) the amino acid sequence shown in SEQ ID No. 1; (2) Compared with the sequence shown in SEQ ID No. 1, one or more amino acids are added, deleted or substituted, and the function of acyltransferase is not affected.

2. A gene encoding the acyltransferase CsAAT1 according to claim 1, It is characterized in that The nucleotide sequence of the gene includes any of the following: (1) the nucleotide sequence shown in SEQ ID No. 2; (2) A sequence having 90% or more homology with the sequence shown in SEQ ID No.

2.

3. A primer pair for amplifying the gene according to claim 2, It is characterized in that It includes an upstream primer with a nucleotide sequence as shown in SEQ ID No.3 and a downstream primer as shown in SEQ ID No.

4.

4. A recombinant expression vector comprising the gene of claim 2 and expressing the acyltransferase CsAAT1 of claim 1.

5. A host cell expressing the acyltransferase CsAAT1 according to claim 1.

6. A method for producing the acyltransferase CsAAT1 according to claim 1, It is characterized in that The method comprises inducing the host cell of claim 5 to express, and obtaining the acyltransferase CsAAT1 after extraction and purification.

7. Use of the acyltransferase CsAAT1 according to claim 1 or the acyltransferase CsAAT1 produced by the method according to claim 5 in in vitro enzymatic synthesis of acylated anthocyanins.

8. A method for synthesizing acylated anthocyanins by enzymatic method in vitro, It is characterized in that The following steps are involved: The enzyme reaction system is configured with aliphatic coenzyme A as an acyl donor and anthocyanin as a substrate to carry out an enzyme catalytic reaction to obtain acylated anthocyanin.

9. The method according to claim 8, It is characterized in that The aliphatic CoA includes malonyl CoA or acetyl CoA; The anthocyanin includes cyanidin-3-O-glucoside, peonidin-3-O-glucoside, delphinidin-3-O-glucoside or cyanidin-3-O-galactoside.

10. Use of the gene according to claim 2 in cultivating plant varieties or strains that catalyze the acylation modification of anthocyanins in vivo.

Citation Information

Cited By

  • Echinacea purpurea SCPL family acyltransferase EpCYS gene and application thereof

    CN119331891A